AutismOne is a nonprofit, parent-driven organization that provides education and supports advocacy efforts for children and families touched by an autism diagnosis.

Join Dr. Elice at the upcoming Spring Conference in Chicago as he gives updates on pioglitazone immunotherapy for autism.

Ten years ago, Dr. Michael Elice co-published a study on the effects of Pioglitazone (Actos) therapy in autistic patients. Actos is an FDA-approved drug for the treatment of Type 2 Diabetes. He will review the initial study and updated research on how this medication may be helpful in improving hyperactivity and stereotypical behaviors in autism spectrum patients.

Please join Dr. Elice at the upcoming intensive CME Functional & Translational Medicine Conference training in the field of neuro-developmental disorders and special needs children. Embrace innovative treatment options, while discovering solutions to advance your practice in this fast-growing medical specialty. We welcome you to become a part of this elite core of medical professionals dedicated to remain at the forefront of cutting-edge medical research and treatment option for special needs children.

AutismOne is a nonprofit, parent-driven organization that provides education and supports advocacy efforts for children and families touched by an autism diagnosis. 

Join Dr. Elice at the upcoming Spring Conference in Colorado Springs as he gives updates on pioglitazone immunotherapy for autism.

Ten years ago, Dr. Michael Elice co-published a study on the effects of Pioglitazone (Actos) therapy in autistic patients. Actos is an FDA-approved drug for the treatment of Type 2 Diabetes. He will review the initial study and updated research on how this medication may be helpful in improving hyperactivity and stereotypical behaviors in autism spectrum patients.

Please join Dr. Elice at the upcoming intensive CME Functional & Translational Medicine Conference training in the field of neuro-developmental disorders and special needs children. Embrace innovative treatment options, while discovering solutions to advance your practice in this fast-growing medical specialty. We welcome you to become a part of this elite core of medical professionals dedicated to remain at the forefront of cutting-edge medical research and treatment option for special needs children.